Mark Christopher Murray, EVP, Biomaterials & AT at Avantor, holds 11.60K shares in Celanese (Ticker: CE), holds 18.68K shares in Avantor (Ticker: AVTR). Most recently, Mark Christopher Murray Bought ― shares of Celanese on Mar 11, 2024 for an estimated value of 93.39K.